{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825896158948992.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.jhep.2008.10.017"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0168827808007150?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0168827808007150?httpAccept=text/plain"}}],"dc:title":[{"@value":"Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825896158948992","@type":"Researcher","foaf:name":[{"@value":"Daniel Shouval"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948994","@type":"Researcher","foaf:name":[{"@value":"Ching-Lung Lai"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948993","@type":"Researcher","foaf:name":[{"@value":"Ting-Tsung Chang"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948996","@type":"Researcher","foaf:name":[{"@value":"Hugo Cheinquer"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948866","@type":"Researcher","foaf:name":[{"@value":"Paul Martin"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948867","@type":"Researcher","foaf:name":[{"@value":"Giampiero Carosi"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948868","@type":"Researcher","foaf:name":[{"@value":"Steven Han"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948869","@type":"Researcher","foaf:name":[{"@value":"Sabahattin Kaymakoglu"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948995","@type":"Researcher","foaf:name":[{"@value":"Ricardo Tamez"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948870","@type":"Researcher","foaf:name":[{"@value":"Joanna Yang"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948864","@type":"Researcher","foaf:name":[{"@value":"Daniel Tenney"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896158948865","@type":"Researcher","foaf:name":[{"@value":"Helena Brett-Smith"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01688278"}],"prism:publicationName":[{"@value":"Journal of Hepatology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2009-02","prism:volume":"50","prism:number":"2","prism:startingPage":"289","prism:endingPage":"295"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0168827808007150?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0168827808007150?httpAccept=text/plain"}],"createdAt":"2008-11-20","modifiedAt":"2018-12-24","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681421863424","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The Forefront of Treatment of Type B/C Chlonic Hepatitis."},{"@language":"ja","@value":"B型・C型慢性肝炎治療の最前線"},{"@value":"医学と医療の最前線 B型・C型慢性肝炎治療の最前線"},{"@language":"ja-Kana","@value":"イガク ト イリョウ ノ サイゼンセン Bガタ Cガタ マンセイ カンエン チリョウ ノ サイゼンセン"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.jhep.2008.10.017"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_ZJ6n34hySmGQvVjP5Y9uFaNry7b"},{"@type":"CROSSREF","@value":"10.2169/naika.99.3080_references_DOI_ZJ6n34hySmGQvVjP5Y9uFaNry7b"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_ZJ6n34hySmGQvVjP5Y9uFaNry7b"}]}